FDA Gives Green Signal To Sanofi-Aventis SA's Cancer Drug Taxotere
French drug maker Sanofi-Aventis SA announced on Thursday that the US Food and Drug Administration has approved its cancer drug Taxotere to treat patients with stomach cancer.// This approval means that Taxotere can be used in combination with chemotherapy drugs cisplatin and 5-fluorouracil to treat stomach cancers that have not been treated with chemotherapy. Taxotere is also approved...Free Access to Taxotere Instills New Hope among Early Stage Breast Cancer Patients
National Institute for Health and Clinical Excellence said that 10,000 breast cancer patients who are in their early stage of the disease would be given free access to// Taxotere, a chemotherapy drug. This drug was initially given to those suffering from late-stage breast cancer. Statistics said that this initiative would save more than 600 lives of patients suffering from breast cancer...Head and Neck Cancer-Taxotere Approved
Taxotere(docetaxel) from Sanofi-Aventis has been approved for its treatment by the FDA, following a clinical trial. The study showed that patients given chemotherapy with// Taxotere survived an average of 11.4 months without disease progression, as compared to 8.3 months with standard drugs. The drug will be used before radiation, in combination with cisplatin and fluorouracil chemoth...Taxotere Improves Survival in Advanced Prostate Cancer
Sanofi-Aventis, one of the world's leading pharmaceutical companies, issued a press release that stated Taxotere (docetaxel) improves survival in patients// with metastatic prostate cancer. A Phase III clinical trial named TAX 327 compared Taxotere plus prednisone to Novantrone (mitoxantrone) plus prednisone. The study included a little over a thousand men who had recurrences or spre...